Neuphoria Therapeutics Inc. - Common Stock (NEUP) Earnings Date, Estimates & Call Transcripts $4.88 -0.17 (-3.37%) As of 02/21/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsOwnershipSEC FilingsTrends Neuphoria Therapeutics Inc. - Common Stock Latest Earnings SummaryUpcoming Q3 Earnings DateMar. 13Before Market OpensEstimatedActual EPS (Feb. 14) -$1.23 Beat By $0.78 Consensus EPS (Feb. 14) -$2.01 Neuphoria Therapeutics Inc. - Common Stock released Q2 2025 earnings on February 14, 2025, reporting an EPS of -$1.23, which beat analysts' consensus estimates of -$2.01 by $0.78. Quarterly revenue was reported to be $660 billion. With a trailing EPS of $0.00, Neuphoria Therapeutics Inc. - Common Stock's earnings are expected to decrease next year, from ($1.56) to ($1.85) per share. NEUP Upcoming EarningsNeuphoria Therapeutics Inc. - Common Stock's next earnings date is estimated for Thursday, March 13, 2025, based off prior year's reporting schedules. Get Neuphoria Therapeutics Inc. - Common Stock Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neuphoria Therapeutics Inc. - Common Stock and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNEUP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NEUP Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Neuphoria Therapeutics Inc. - Common Stock Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$2.01-$2.01-$2.01Q3 20251-$0.47-$0.47-$0.47Q4 20251-$1.26-$1.26-$1.2620253-$3.74-$3.74-$3.74Q1 20261-$0.55-$0.55-$0.55Q2 20261-$0.61-$0.61-$0.61Q3 20261-$0.42-$0.42-$0.42Q4 20261-$0.42-$0.42-$0.42FY 20264($2.00)($2.00)($2.00) Neuphoria Therapeutics Inc. - Common Stock Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 3/13/2025(Estimated)-------2/14/2025Q2 2025-$2.01-$1.23+$0.78-$1.23-$660.00B Neuphoria Therapeutics Inc. - Common Stock Earnings - Frequently Asked Questions When is Neuphoria Therapeutics Inc. - Common Stock's earnings date? Neuphoria Therapeutics Inc. - Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates. Learn more on NEUP's earnings history. Did Neuphoria Therapeutics Inc. - Common Stock beat their earnings estimates last quarter? In the previous quarter, Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP) reported ($1.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.01) by $0.78. Learn more on analysts' earnings estimate vs. NEUP's actual earnings. How much revenue does Neuphoria Therapeutics Inc. - Common Stock generate each year? Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP) has a recorded annual revenue of $10,000.00. How much profit does Neuphoria Therapeutics Inc. - Common Stock generate each year? Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP) has a recorded net income of -$15.49 million. NEUP has generated $0.00 earnings per share over the last four quarters. What is Neuphoria Therapeutics Inc. - Common Stock's EPS forecast for next year? Neuphoria Therapeutics Inc. - Common Stock's earnings are expected to decrease from ($1.56) per share to ($1.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies BFRG Earnings Date IXHL Earnings Date RLYB Earnings Date PMN Earnings Date CVM Earnings Date SNYR Earnings Date MRNS Earnings Date COEP Earnings Date NKGN Earnings Date CMMB Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles The Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity? This page (NASDAQ:NEUP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuphoria Therapeutics Inc. - Common Stock Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuphoria Therapeutics Inc. - Common Stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
